S (Seamus) Kent

Erasmus School of Health Policy & Management

Assistant professor | Health Technology Assessment (HTA)

Email: kent@eshpm.eur.nl

Pure profile

Work

Noor Wortelboer, Seamus Kent, Hedwig M. Blommestein, Annemiek Van Ommen-Nijhof, Vincent Van der Noort, Esther Van den Pol, Cristina Guerrero Páez, Aart Beeker, Karin Beelen, Lisanne C. Hamming, Joan B. Heijns, Aafke H. Honkoop, Paul C. De Jong, Quirine C. Van Rossum-Schornagel, Christa Van Schaik-Van de Mheen, Jolien Tol, Cathrien S. Tromp-Van Driel, Suzan Vrijaldenhoven, A. Elise Van Leeuwen-Stok, Gabe S. Sonke, Agnes Jager & Inge R. Konings (2026) - Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial - Journal of the National Cancer Institute, 118 (3), 502-510 - doi: 10.1093/jnci/djaf334 - [link]
Noor Wortelboer, Seamus Kent, Inge R. Konings, Annemiek van Ommen-Nijhof, Vincent van der Noort, Esther van den Pol, Cristina Guerrero Páez, Marlies L. van Bekkum, Franchette W.P.J. van den Berkmortel, Helga J. Droogendijk, Danny Houtsma, Hendrika M. Oosterkamp, Annemieke van der Padt-Pruijsten, Ester J.M. Siemerink, Jolien Tol, Annette A. van Zweeden, A. Elise van Leeuwen-Stok, Gabe S. Sonke, Agnes Jager & Hedwig Blommestein (2025) - Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial - European Journal of Cancer, 231 - doi: 10.1016/j.ejca.2025.116051 - [link]
Katsiaryna Bykov, Ashley Jaksa, Jennifer L. Lund, Jessica M. Franklin, Cynthia J. Girman, Madlen Gazarian, Hongbo Yuan, Stephen Duffield, Seamus Kent & Elisabetta Patorno (2025) - APPRAISE: A Tool for Appraising Potential for Bias in Real-World Evidence Studies on Medication Effectiveness or Safety - Value in Health, 28 (12), 1849-1856 - doi: 10.1016/j.jval.2025.07.024 - [link]
Alind Gupta, Evie Merinopoulou, Stephen J. Duffield, Manuel Gomes, Seamus Kent, Nicolas Scheuer, Gerardo Machnicki & Thibaut Sanglier (2025) - Estimating per-protocol effects in external comparator analyses using real-world data - Journal of Comparative Effectiveness Research, 14 (11) - doi: 10.57264/cer-2025-0029 - [link]
Alind Gupta, Grace Hsu, Seamus Kent, Stephen J. Duffield, Evie Merinopoulou, Alexandre Lockhart, Paul Arora, Joshua Ray, Samantha Wilkinson, Nicolas Scheuer, Sreeram V. Ramagopalan, Rolf H.H. Groenwold, Sanjay Popat & Miguel A. Hernán (2025) - Quantitative Bias Analysis for Single-Arm Trials With External Control Arms - JAMA network open, 8 (3) - doi: 10.1001/jamanetworkopen.2025.2152 - [link]
Mina Tadrous, Theresa Aves, Christine Fahim, Jessica Riad, Nicole Mittmann, Daniel Prieto-Alhambra, Donna R. Rivera, Kelvin Chan, Lisa M. Lix, Seamus Kent, Dalia Dawoud, Jason Robert Guertin, James Ted McDonald, Jeff Round, Scott Klarenbach, Sanja Stanojevic, Mary A. De Vera, Erin Strumpf, Robert W. Platt, Farah Husein, Laurie Lambert & Kaleen N. Hayes (2024) - Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making - Journal of Clinical Epidemiology, 176 - doi: 10.1016/j.jclinepi.2024.111545 - [link]
Rachael L. Fleurence, Seamus Kent, Blythe Adamson, James Tcheng, Ran Balicer, Joseph S. Ross, Kevin Haynes, Patrick Muller, Jon Campbell, Elsa Bouée-Benhamiche, Sebastián García Martí & Scott Ramsey (2024) - Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force - Value in Health, 27 (6), 692-701 - doi: 10.1016/j.jval.2024.01.019 - [link]
Philani Mpofu, Seamus Kent, Páll Jónsson, Harlan Pittell, Brad Groves, Ivy Altomare, Amanda Copeland, Shrujal Baxi, Danielle Bargo, Arun Sujenthiran & Blythe Adamson (2023) - Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study - BMJ Open, 13 (10) - doi: 10.1136/bmjopen-2023-074559 - [link]
Caroline E. Dale, Rohan Takhar, Raymond Carragher, Michail Katsoulis, Fatemeh Torabi, Stephen Duffield, Seamus Kent, Tanja Mueller, Amanj Kurdi, Thu Nguyen Le Anh, Stuart McTaggart, Hoda Abbasizanjani, Sam Hollings, Andrew Scourfield, Ronan A. Lyons, Rowena Griffiths, Jane Lyons, Gareth Davies, Daniel Harris, Alex Handy, Mehrdad A. Mizani, Christopher Tomlinson, Johan H. Thygesen, Mark Ashworth, Spiros Denaxas, Amitava Banerjee, Jonathan A. C. Sterne, Paul Brown, Ian Bullard, Rouven Priedon, Mamas A. Mamas, Ann Slee, Paula Lorgelly, Munir Pirmohamed, Kamlesh Khunti, Andrew D. Morris, Cathie Sudlow, Ashley Akbari, Marion Bennie, Naveed Sattar & Reecha Sofat (2023) - The impact of the COVID-19 pandemic on cardiovascular disease prevention and management - Nature Medicine, 29 (1), 219-225 - doi: 10.1038/s41591-022-02158-7
Ashley Jaksa, Liza Gibbs, Seamus Kent, Shaun Rowark, Stephen Duffield, Manuj Sharma, Lynne Kincaid, Ayad Ali, Amanda Patrick, Priya Govil, Pall Jonsson & Nicolle Gatto (2022) - Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study - BMJ Open, 12 (10) - doi: 10.1136/bmjopen-2022-064662 - [link]